Target intelligence / Profile preview

Solute carrier family 2 member 1 (GLUT1) and corneal glycocalyx components (GLUT1/Glycocalyx)

Target
GLUT1/Glycocalyx
Molecular classification
Transporter, Other
01

Overview

The human corneal epithelial GLUT-1 and glycocalyx components constitute the primary biochemical and physical interface of the ocular surface. GLUT-1, or Solute carrier family 2 member 1, is a uniporter protein responsible for the facilitated diffusion of glucose into corneal epithelial cells, ensuring metabolic support for the avascular cornea [PubMed: 10889430]. The glycocalyx is a dense network of membrane-associated mucins, such as MUC1, MUC4, and MUC16, which provide a hydrophilic environment that stabilizes the tear film and prevents pathogen adhesion [PubMed: 21846365]. This system is a major focus in ophthalmology because GLUT-1 can be exploited for the targeted delivery of glucose-conjugated prodrugs to improve drug penetration into the eye [PubMed: 23830730]. By mimicking natural substrates, these prodrugs utilize the transporter's mechanism to bypass the restrictive corneal barrier. Conversely, degradation or dysfunction of the glycocalyx components is a hallmark of dry eye disease and diabetic keratopathy, leading to increased susceptibility to infection and mechanical damage [PubMed: 15111340]. Therapeutic strategies often aim to either restore glycocalyx integrity or utilize the GLUT-1 pathway for efficient drug uptake.

Other names
SLC2A1Glucose transporter member 1Ocular surface glycocalyxCorneal mucinsMUC1MUC16Membrane-associated mucins
02

Mechanism of action

Facilitated diffusion of glucose and glucose-conjugated prodrugs via GLUT1; maintenance of ocular surface hydration and pathogen defense via glycocalyx mucins.

03

Biological functions

Glucose transportBarrier functionCell protectionLubricationCell adhesion
04

Disease associations

Dry eye syndromeDiabetic keratopathyCorneal neovascularizationInfectionOcular surface disease
05

Safety considerations

Potential inhibition of corneal glucose metabolismDisruption of the protective tear film barrierIncreased susceptibility to corneal infectionEpithelial toxicity from transporter saturation
06

Interacting drugs

Ganciclovir-glucose prodrug

5 more in the full profile.

07

Biomarkers

GLUT1 expression levelsMucin-16 (MUC16) concentrationRose Bengal staining scoreTear film break-up time (TBUT)

Beyond the preview

Go deeper on Solute carrier family 2 member 1 (GLUT1) and corneal glycocalyx components (GLUT1/Glycocalyx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 2 member 1 (GLUT1) and corneal glycocalyx components (GLUT1/Glycocalyx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call